Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T DOLLERY

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1985
The decision to treat: profiling benefitC T Dollery
Clinical Pharmacology and Therapeutics|May 1, 1976
Drug regulation in the United KingdomC T Dollery
European Heart Journal|December 1, 1987
Beta-adrenoceptor blocking drugs in primary and secondary prevention of myocardial infarctionC T Dollery
Journal of Cardiovascular Pharmacology|January 1, 1988
Beta-adrenoceptor blockade: past, present, and futureC T Dollery
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Management of hypertension: risk-benefit ratioC T Dollery
Federation Proceedings|February 1, 1983
Hypertension and new antihypertensive drugs: clinical perspectivesC T Dollery
Clinical Pharmacology and Therapeutics|September 14, 2007
Beyond genomicsC T Dollery
The American Journal of Medicine|January 5, 1987
Risk predictors, risk indicators, and benefit factors in hypertensionC T Dollery
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1987
An update on the Medical Research Council Hypertension TrialC T Dollery
American Journal of Hypertension|February 1, 1991
Clinical pharmacology of calcium antagonistsC T Dollery
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1985
The decision to treat: profiling benefitC T Dollery
Clinical Pharmacology and Therapeutics|May 1, 1976
Drug regulation in the United KingdomC T Dollery
European Heart Journal|December 1, 1987
Beta-adrenoceptor blocking drugs in primary and secondary prevention of myocardial infarctionC T Dollery
Journal of Cardiovascular Pharmacology|January 1, 1988
Beta-adrenoceptor blockade: past, present, and futureC T Dollery
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Management of hypertension: risk-benefit ratioC T Dollery
Federation Proceedings|February 1, 1983
Hypertension and new antihypertensive drugs: clinical perspectivesC T Dollery
Clinical Pharmacology and Therapeutics|September 14, 2007
Beyond genomicsC T Dollery
The American Journal of Medicine|January 5, 1987
Risk predictors, risk indicators, and benefit factors in hypertensionC T Dollery
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1987
An update on the Medical Research Council Hypertension TrialC T Dollery
American Journal of Hypertension|February 1, 1991
Clinical pharmacology of calcium antagonistsC T Dollery
Pageof 22